{"id":"W4405296698","doi":"10.1093/ecco-jcc/jjae188","title":"Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison","year":2024,"lang":"en","type":"article","venue":"Journal of Crohn s and Colitis","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Vifor Pharma; Wellcome Trust; Australian Government; Gilead Sciences; Pfizer; UK Research and Innovation; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Medicine; Tofacitinib; Ulcerative colitis; Internal medicine; Gastroenterology; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006643042,0.0007270302,0.001718416,0.0007318782,0.0003888977,0.001183657,0.0008381327,0.001401163,0.003752586],"category_scores_gemma":[0.01027227,0.0005053655,0.00418812,0.0006908067,0.0006490184,0.001110677,0.0009159502,0.001233601,0.0003884346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005155519,"about_ca_system_score_gemma":0.0003742042,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000596565,"about_ca_topic_score_gemma":0.0003822445,"domain_scores_codex":[0.9957653,0.002302658,0.0004772703,0.0008510658,0.0002995767,0.0003039936],"domain_scores_gemma":[0.9934325,0.002902325,0.002374757,0.0006339007,0.0002145403,0.0004418294],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.3983902,0.003451783,0.4940723,0.001626954,0.05064626,0.0006608365,0.00046595,0.008678034,0.002289584,0.001939821,0.002970689,0.03480759],"study_design_scores_gemma":[0.08425818,0.110758,0.6682878,0.0005236231,0.03448071,0.002283278,0.001300137,0.0786091,0.001459258,0.009626087,0.008047155,0.0003667326],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941539,0.002203504,0.001752773,0.0001847438,0.0001352711,0.0002066416,0.0006904656,0.00001172545,0.0006610269],"genre_scores_gemma":[0.998102,0.0003149111,0.0003806945,0.0001082903,0.00006031589,0.0001397354,0.0006587683,0.000005256685,0.0002301301],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006643042,"threshold_uncertainty_score":0.03513217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01175184138534486,"score_gpt":0.2557742016070988,"score_spread":0.2440223602217539,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}